Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer Patients
Interventions: GENETIC: polymorphism analysis|DRUG: Doxorubicin-Cyclophosphamide regimen
Sponsor: Damanhour University
Collaborators: Al-Azhar University